Amgen

Amgen Named 2026 World's Most Ethical Company by Ethisphere

安进

Amgen's 15-minute chart shows Bollinger Bands narrowing and KDJ death cross.

Wells Fargo Boosts Amgen Price Target to $390, Citing Expansion Opportunities

Amgen's 15-minute chart shows MACD Death Cross, KDJ Death Cross signals.

Amgen Triggers MACD Death Cross, KDJ Death Cross on 15-Minute Chart.

Catalyst<ul> <li>The company maintains strong cash reserves and asset value relative to its market capitalization.</li></ul>Risk<ul> <li>Multiple recent technical signals including RSI Overbought and MACD Death Cross indicate bearish momentum for AMGN.</li> <li>Analyst consensus remains predominantly Neutral with three out of four ratings suggesting limited upside.</li></ul>

Key Factors

Amgen reported Q4 earnings of $5.29 per share and raised its FY2026 EPS guidance to a range of 21.60 to 23.00.Wells Fargo increased its price target on Amgen to $390, while Jefferies initiated coverage with a $350 target.Amgen stock surged 2.17% intraday to close near $356, outperforming the broader S&P 500 market gains.Amgen was designated as one of the 2026 World's Most Ethical Companies by Ethisphere.

AMGN News